KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Gross Profit for 4 consecutive years, with $49.4 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Gross Profit rose 13750.0% year-over-year to $49.4 million, compared with a TTM value of -$330.3 million through Sep 2023, down 525.07%, and an annual FY2022 reading of -$226.7 million, down 2596.06% over the prior year.
  • Gross Profit was $49.4 million for Q3 2023 at Ginkgo Bioworks Holdings, up from -$91.7 million in the prior quarter.
  • Across five years, Gross Profit topped out at $60.3 million in Q4 2021 and bottomed at -$297.7 million in Q4 2022.
  • Average Gross Profit over 4 years is -$24.4 million, with a median of -$2.4 million recorded in 2021.
  • The sharpest move saw Gross Profit plummeted 593.42% in 2022, then soared 13750.0% in 2023.
  • Year by year, Gross Profit stood at $11.5 million in 2020, then surged by 423.19% to $60.3 million in 2021, then tumbled by 593.42% to -$297.7 million in 2022, then soared by 116.6% to $49.4 million in 2023.
  • Business Quant data shows Gross Profit for DNA at $49.4 million in Q3 2023, -$91.7 million in Q2 2023, and $9.7 million in Q1 2023.